The 'Dispatched' Podcast copertina

The 'Dispatched' Podcast

The 'Dispatched' Podcast

Di: Daily Dispatch
Ascolta gratuitamente

Offerte di stagione | 0,99 €/mese per i primi 3 mesi

A seguire 9,99 €/mese – si applicano condizioni. Puoi disdire mensilmente.

BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.

© 2026 The 'Dispatched' Podcast
Politica e governo
  • The 'Dispatched' Podcast Week in Review - Series 5. Ep.35
    Oct 9 2026

    Should industry groups present the agreement negotiations to patient groups and 'invited' stakeholders, and if so, what should they say? Why the private market for GLP-1 medicines could be a historic catalyst for the changes so many want.

    Mostra di più Mostra meno
    53 min
  • The 'Dispatched' Podcast Week in Review - Series 5. Ep.34
    Oct 2 2026

    The impact of new media guidance from Australia's health technology regulator can now be assessed against the backdrop of its use of an AI platform initially developed for, and still used by, intelligence and law enforcement agencies. Why is the debate in Australia so limited, confined to a small group of privileged insiders, and why do so many appear uncomfortable with patients having meaningful rights?

    Mostra di più Mostra meno
    51 min
  • The 'Dispatched' Week in Review - 25 September
    Sep 25 2026

    A week dominated by discussions about AI that was all of good, less good, self-serving and ironic. Surely we can grasp the opportunity while managing the risks. A dehumanising outcome for women living with a form of advanced breast cancer must surely trigger ministerial intervention and another highly questionable Intergenerational Report.

    Mostra di più Mostra meno
    39 min
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione